Suppr超能文献

2型糖尿病患者的单一疗法

Monotherapy in Patients with Type 2 Diabetes Mellitus.

作者信息

Rhee Sang Youl, Kim Hyun Jin, Ko Seung Hyun, Hur Kyu Yeon, Kim Nan Hee, Moon Min Kyong, Park Seok O, Lee Byung Wan, Choi Kyung Mook, Kim Jin Hwa

机构信息

Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.

Division of Endocrinology and Metabolism, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.

出版信息

Diabetes Metab J. 2017 Oct;41(5):349-356. doi: 10.4093/dmj.2017.41.5.349.

Abstract

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

摘要

为了提高生活质量并预防与糖尿病相关的慢性并发症,从2型糖尿病(T2DM)诊断的早期阶段就需要强化生活方式改变和适当用药。在为糖尿病患者使用第一种药物时,应考虑患者的临床特征、药物疗效、副作用和成本来选择合适的治疗方法。一般来说,推荐使用二甲双胍作为口服降糖单药治疗的首选药物,因为其具有出色的降糖效果、相对较低的副作用、长期验证的安全性、低血糖风险低以及体重增加少。如果二甲双胍难以作为一线治疗药物使用,则应根据临床情况选择其他合适的药物。如果单药治疗未达到血糖控制目标,应立即启动具有不同作用机制的联合治疗。

相似文献

1
Monotherapy in Patients with Type 2 Diabetes Mellitus.2型糖尿病患者的单一疗法
Diabetes Metab J. 2017 Oct;41(5):349-356. doi: 10.4093/dmj.2017.41.5.349.
2
Monotherapy in patients with type 2 diabetes mellitus.2型糖尿病患者的单药治疗。
Korean J Intern Med. 2017 Nov;32(6):959-966. doi: 10.3904/kjim.2017.312. Epub 2017 Oct 23.

引用本文的文献

本文引用的文献

2
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.卡格列净与 2 型糖尿病的心血管和肾脏事件。
N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.
6
8. Pharmacologic Approaches to Glycemic Treatment.8. 血糖治疗的药理学方法。
Diabetes Care. 2017 Jan;40(Suppl 1):S64-S74. doi: 10.2337/dc17-S011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验